This clinical study is evaluating a new treatment for Inflammatory Conditions such as Psoriasis and Inflammatory Bowel Disease (IBD). The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Be 18 to 55 years old
Be a healthy male or female